Document | Clinical and Pharmacological Implications of mGluR5 Modulation in Parkinson’s Disease | ID: nc580n16v

Item Description

Description	This presentation includes the literature of mGlu5 synaptic signaling/modulation and its influence in the design of the current ongoing (as of April 2025) clinical trial ALX 923-107
Date created	April 15, 2025
Creator	Patel, Ashna
Orcid	0009-0004-2267-9920
Subject	Parkinson’s Disease silent allosteric modulation neurodegeneration mGluR5 modulation
Permanent Link:	http://hdl.handle.net/2193/NC580N16V

En Collection:

Miniatura	Título	Fecha de subida	Visibilidad	Acciones
	Patel_Ashna_MBS_Scholar_s_Day.pdf	2025-06-11	Público	Descargar
	References-Ashna_Patel.pdf	2025-06-13	Público	Descargar